Intracoronary administration of streptokinase in a canine model disturbances in thromboxane a2-prostacyclin balance

Gary J. Becker, Donald L. Kreipke, Robert W. Holden, R. Gerald Dreesen, Kenneth Ryder, Bruce Petersen, Andrew P. Evan, Phillip J. Bendick, Thomas D. Franklin, Eugene C. Klatte

Research output: Contribution to journalArticle

Abstract

The potential impact of local intracoronary infusion of streptokinase (SK) on vascular prostaglandin synthetic pathways was studied in a canine model. Control animals (n = 10) underwent left coronary artery (LC A) infusion of50,000 units SK for 90 minutes; experimental animals (n = 10) underwent LC A infusion of normal saline. Plasma samples for radioimmunoassay (RI A) of prostacyclin (PGI-2) and thromboxane (TXA-2) were obtained from the coronary sinus (CS) as follows: One sample pre infusion, six samples during infusion, and three samples post in fusion in each animal. Comparisons between control and experimental plasma levels of PGI-2 and TXA-2 were made for each sampling time. The PGI-2 levels remained at or below the lower limits of detect ability by RIA (the most sensitive assay available) in both control and experimental animals. TXA-2 levels were higher in experimental than in control animals at all sampling times, with the most significant differences occurring in samples 3 (after 30 minutes of infusion,.001 <P <.01), 4 (after 45 minutes of infusion,.05 <P <.10), and 5 (after 60 minutes of infusion,.02 < P <.05). We suggest (1) it is unlikely that any of the beneficial effects of coronary streptokinase infusions are PGI-2-mediated, (2) that the TXA-2 increases in our model may represent a patho physiologic-biochemical correlate of previously identified morphologic evidence of endothelial damage in animals infused with fibrinolytic agents, and (3) that our findings may indicate that fibrinolytic infusions produce competing effects: Lysis of thrombi and endothelial injury with TXA-2 production. Investigation into a possible dose response relationship and possible adjunctive use of antiplatelet drugs, antithromboxane drugs, and calcium channel blockers is warranted.

Original languageEnglish (US)
Pages (from-to)206-209
Number of pages4
JournalInvestigative Radiology
Volume21
Issue number3
DOIs
StatePublished - Mar 1986

Fingerprint

Thromboxane A2
Streptokinase
Epoprostenol
Canidae
Coronary Vessels
Synthetic Prostaglandins
Fibrinolytic Agents
Coronary Sinus
Thromboxanes
Platelet Aggregation Inhibitors
Calcium Channel Blockers
Radioimmunoassay
Blood Vessels
Thrombosis
Wounds and Injuries
Pharmaceutical Preparations

Keywords

  • Animal studies
  • Coronary arteries
  • Fibrinolysis
  • Prostaglandins

ASJC Scopus subject areas

  • Radiology Nuclear Medicine and imaging
  • Radiological and Ultrasound Technology

Cite this

Becker, G. J., Kreipke, D. L., Holden, R. W., Gerald Dreesen, R., Ryder, K., Petersen, B., ... Klatte, E. C. (1986). Intracoronary administration of streptokinase in a canine model disturbances in thromboxane a2-prostacyclin balance. Investigative Radiology, 21(3), 206-209. https://doi.org/10.1097/00004424-198603000-00003

Intracoronary administration of streptokinase in a canine model disturbances in thromboxane a2-prostacyclin balance. / Becker, Gary J.; Kreipke, Donald L.; Holden, Robert W.; Gerald Dreesen, R.; Ryder, Kenneth; Petersen, Bruce; Evan, Andrew P.; Bendick, Phillip J.; Franklin, Thomas D.; Klatte, Eugene C.

In: Investigative Radiology, Vol. 21, No. 3, 03.1986, p. 206-209.

Research output: Contribution to journalArticle

Becker, GJ, Kreipke, DL, Holden, RW, Gerald Dreesen, R, Ryder, K, Petersen, B, Evan, AP, Bendick, PJ, Franklin, TD & Klatte, EC 1986, 'Intracoronary administration of streptokinase in a canine model disturbances in thromboxane a2-prostacyclin balance', Investigative Radiology, vol. 21, no. 3, pp. 206-209. https://doi.org/10.1097/00004424-198603000-00003
Becker, Gary J. ; Kreipke, Donald L. ; Holden, Robert W. ; Gerald Dreesen, R. ; Ryder, Kenneth ; Petersen, Bruce ; Evan, Andrew P. ; Bendick, Phillip J. ; Franklin, Thomas D. ; Klatte, Eugene C. / Intracoronary administration of streptokinase in a canine model disturbances in thromboxane a2-prostacyclin balance. In: Investigative Radiology. 1986 ; Vol. 21, No. 3. pp. 206-209.
@article{2485684936604888bc539dbd3d23c888,
title = "Intracoronary administration of streptokinase in a canine model disturbances in thromboxane a2-prostacyclin balance",
abstract = "The potential impact of local intracoronary infusion of streptokinase (SK) on vascular prostaglandin synthetic pathways was studied in a canine model. Control animals (n = 10) underwent left coronary artery (LC A) infusion of50,000 units SK for 90 minutes; experimental animals (n = 10) underwent LC A infusion of normal saline. Plasma samples for radioimmunoassay (RI A) of prostacyclin (PGI-2) and thromboxane (TXA-2) were obtained from the coronary sinus (CS) as follows: One sample pre infusion, six samples during infusion, and three samples post in fusion in each animal. Comparisons between control and experimental plasma levels of PGI-2 and TXA-2 were made for each sampling time. The PGI-2 levels remained at or below the lower limits of detect ability by RIA (the most sensitive assay available) in both control and experimental animals. TXA-2 levels were higher in experimental than in control animals at all sampling times, with the most significant differences occurring in samples 3 (after 30 minutes of infusion,.001 <P <.01), 4 (after 45 minutes of infusion,.05 <P <.10), and 5 (after 60 minutes of infusion,.02 < P <.05). We suggest (1) it is unlikely that any of the beneficial effects of coronary streptokinase infusions are PGI-2-mediated, (2) that the TXA-2 increases in our model may represent a patho physiologic-biochemical correlate of previously identified morphologic evidence of endothelial damage in animals infused with fibrinolytic agents, and (3) that our findings may indicate that fibrinolytic infusions produce competing effects: Lysis of thrombi and endothelial injury with TXA-2 production. Investigation into a possible dose response relationship and possible adjunctive use of antiplatelet drugs, antithromboxane drugs, and calcium channel blockers is warranted.",
keywords = "Animal studies, Coronary arteries, Fibrinolysis, Prostaglandins",
author = "Becker, {Gary J.} and Kreipke, {Donald L.} and Holden, {Robert W.} and {Gerald Dreesen}, R. and Kenneth Ryder and Bruce Petersen and Evan, {Andrew P.} and Bendick, {Phillip J.} and Franklin, {Thomas D.} and Klatte, {Eugene C.}",
year = "1986",
month = "3",
doi = "10.1097/00004424-198603000-00003",
language = "English (US)",
volume = "21",
pages = "206--209",
journal = "Investigative Radiology",
issn = "0020-9996",
publisher = "Lippincott Williams and Wilkins",
number = "3",

}

TY - JOUR

T1 - Intracoronary administration of streptokinase in a canine model disturbances in thromboxane a2-prostacyclin balance

AU - Becker, Gary J.

AU - Kreipke, Donald L.

AU - Holden, Robert W.

AU - Gerald Dreesen, R.

AU - Ryder, Kenneth

AU - Petersen, Bruce

AU - Evan, Andrew P.

AU - Bendick, Phillip J.

AU - Franklin, Thomas D.

AU - Klatte, Eugene C.

PY - 1986/3

Y1 - 1986/3

N2 - The potential impact of local intracoronary infusion of streptokinase (SK) on vascular prostaglandin synthetic pathways was studied in a canine model. Control animals (n = 10) underwent left coronary artery (LC A) infusion of50,000 units SK for 90 minutes; experimental animals (n = 10) underwent LC A infusion of normal saline. Plasma samples for radioimmunoassay (RI A) of prostacyclin (PGI-2) and thromboxane (TXA-2) were obtained from the coronary sinus (CS) as follows: One sample pre infusion, six samples during infusion, and three samples post in fusion in each animal. Comparisons between control and experimental plasma levels of PGI-2 and TXA-2 were made for each sampling time. The PGI-2 levels remained at or below the lower limits of detect ability by RIA (the most sensitive assay available) in both control and experimental animals. TXA-2 levels were higher in experimental than in control animals at all sampling times, with the most significant differences occurring in samples 3 (after 30 minutes of infusion,.001 <P <.01), 4 (after 45 minutes of infusion,.05 <P <.10), and 5 (after 60 minutes of infusion,.02 < P <.05). We suggest (1) it is unlikely that any of the beneficial effects of coronary streptokinase infusions are PGI-2-mediated, (2) that the TXA-2 increases in our model may represent a patho physiologic-biochemical correlate of previously identified morphologic evidence of endothelial damage in animals infused with fibrinolytic agents, and (3) that our findings may indicate that fibrinolytic infusions produce competing effects: Lysis of thrombi and endothelial injury with TXA-2 production. Investigation into a possible dose response relationship and possible adjunctive use of antiplatelet drugs, antithromboxane drugs, and calcium channel blockers is warranted.

AB - The potential impact of local intracoronary infusion of streptokinase (SK) on vascular prostaglandin synthetic pathways was studied in a canine model. Control animals (n = 10) underwent left coronary artery (LC A) infusion of50,000 units SK for 90 minutes; experimental animals (n = 10) underwent LC A infusion of normal saline. Plasma samples for radioimmunoassay (RI A) of prostacyclin (PGI-2) and thromboxane (TXA-2) were obtained from the coronary sinus (CS) as follows: One sample pre infusion, six samples during infusion, and three samples post in fusion in each animal. Comparisons between control and experimental plasma levels of PGI-2 and TXA-2 were made for each sampling time. The PGI-2 levels remained at or below the lower limits of detect ability by RIA (the most sensitive assay available) in both control and experimental animals. TXA-2 levels were higher in experimental than in control animals at all sampling times, with the most significant differences occurring in samples 3 (after 30 minutes of infusion,.001 <P <.01), 4 (after 45 minutes of infusion,.05 <P <.10), and 5 (after 60 minutes of infusion,.02 < P <.05). We suggest (1) it is unlikely that any of the beneficial effects of coronary streptokinase infusions are PGI-2-mediated, (2) that the TXA-2 increases in our model may represent a patho physiologic-biochemical correlate of previously identified morphologic evidence of endothelial damage in animals infused with fibrinolytic agents, and (3) that our findings may indicate that fibrinolytic infusions produce competing effects: Lysis of thrombi and endothelial injury with TXA-2 production. Investigation into a possible dose response relationship and possible adjunctive use of antiplatelet drugs, antithromboxane drugs, and calcium channel blockers is warranted.

KW - Animal studies

KW - Coronary arteries

KW - Fibrinolysis

KW - Prostaglandins

UR - http://www.scopus.com/inward/record.url?scp=0022612763&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0022612763&partnerID=8YFLogxK

U2 - 10.1097/00004424-198603000-00003

DO - 10.1097/00004424-198603000-00003

M3 - Article

C2 - 3082791

AN - SCOPUS:0022612763

VL - 21

SP - 206

EP - 209

JO - Investigative Radiology

JF - Investigative Radiology

SN - 0020-9996

IS - 3

ER -